Camosunate Pediatric (0 -1 Yr)

Camosunate® for Children is a pediatric antimalarial medication formulated specifically for infants under 1 year of age. It combines Artesunate and Amodiaquine, two powerful antimalarial agents, to effectively treat uncomplicated Plasmodium falciparum malaria – the most severe form of the disease.

This artemisinin-based combination therapy (ACT) is recommended by the WHO as a first-line treatment for malaria and is specially dosed for safety and effectiveness in infants.

Key Features:

• Formulated for children below 12 months of age

• Contains Artesunate + Amodiaquine in age-appropriate doses

• Effective against chloroquine-resistant Plasmodium falciparum

• Fast-acting, reliable symptom relief and parasite clearance

• Easy-to-administer oral tablets, crushable for convenience

Indications:

• Treatment of acute uncomplicated malaria caused by Plasmodium falciparum

• Suitable for use in malaria-endemic regions

Dosage & Administration:

• Age-specific dosing based on weight and clinical assessment

• Usually administered over 3 days, under medical supervision

• Tablets may be crushed and mixed with a small amount of water or breast milk for easier administration

Precautions:

• Not to be used for severe or complicated malaria

• Use only under medical advice

• Monitor for allergic reactions or gastrointestinal upset

• Ensure full course completion to avoid resistance

Storage:

• Store below 30°C in a cool, dry place

• Protect from moisture and direct sunlight

Note: Always consult a healthcare professional before administering any medication to infants. This product is not for self-medication and should be used strictly under prescription.